Copyright © Inderes 2011 - present. All rights reserved.

I-tech

57.40 SEK

+0.70 %

Less than 1K followers

ITECH

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

+0.70 %
-20.94 %
-35.94 %
-44.00 %
-1.03 %
+15.26 %
+1.06 %
-14.33 %
+132.72 %

I-tech operates in marine technology. The company conducts research and development of substances that inhibit marine fouling on ship hulls. In addition, the products can be used for various marine installations in fish farming and offshore. Customers are found in the marine paint industry and among other players in the shipping industry. I-Tech was founded in 2000 and has its headquarters in Mölndal.

Read more
Market cap
688.67M SEK
Turnover
653.95K SEK
Revenue
179.45M
EBIT %
25.35 %
P/E
17.39
Dividend yield-%
1.74 %
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
5/2
2026

Annual report '25

7/5
2026

Interim report Q1'26

21/8
2026

Interim report Q2'26

ShowingAll content types
Third party research

I-tech: Proposed non-renewal of Selektope in the EU - ABG

* European Commission drafts proposal for non-renewal of Selektope* Limited impact on near-term estimates, EU ~2% of total sales* Voting expected to occur some time in H1'26, final decision in mid-26European Commission drafts proposal for non-renewal...

I-tech

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Third party research

I-tech: Customer slowdown tempers growth - ABG

* Q3 softer due to sizeable customer trimming '25 volumes* '25e-'27e sales cut by 11-6% and '26e-'27e EBIT by 12-8%* We believe I-Tech remains strongly positioned to grow market shareGrowth dampened by customer volume cutsI-Tech reported weaker than ...

I-tech
Third party research

I-tech: Q3 impacted by weaker market conditions - ABG

Sales -18% vs. ABGSCe, EBIT SEK 11m vs. ABGSCe 16m* Newbuild market down 50% y-o-y, affecting growth* Sizeable customer has reduced planned volumes for '25Q3 resultsQ3 sales came in lower than expected at SEK 41m (-18% vs. ABGSCe 50m). The company writes...

I-tech
Third party research

I-tech: Sales recovery expected in Q3 - ABG

* Report out on 17 October* Q3e sales of SEK 50m, +23% y-o-y, EBIT SEK 16m (9m)* Q3 rebound expected after Q2 dip Q3 expectations We estimate Q3 sales of SEK 50m, +23% y-o-y (+35% organic, -12% FX). We expect Q3 to demonstrate that Q2 was a temporary...

I-tech
Third party research

I-tech: A pause, not a stop - ABG

* Weaker Q2 due to natural quarterly variations* Cut '25e-'27e EBIT by 12-13%* Demand intact, rebound expected in Q3Growth halted, but we expect a rebound in Q3I-Tech reported weaker Q2 sales of SEK 32m (-39% vs. ABGSCe, -26% y-o-y) and EBIT of SEK 5m...

I-tech
Third party research

I-tech: Big Q2 miss halts sales growth - ABG

* Sales -39% vs. ABGSCe, EBIT SEK 5m vs. ABGSCe 16m * Weak Q2 due to inventory build-up following strong Q4/Q1* Gross margin continues to improve (59% vs. ABGSCe 56%) Weaker Q2 than expected Sales came in lower than expected at SEK 32m (-39% vs. ABGSCe...

I-tech
Third party research

I-Tech: Resilient growth ahead despite FX headwinds - ABG

Q2e sales of SEK 52m, 22% y-o-y, adj. EBIT of SEK 17m (12m) FX headwinds, but we expect customer growth to remain solid Minor estimate changes ahead of report Q2 expectations We anticipate a negative FX impact in Q2 from the depreciation of the USD/SEK...

I-tech
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.